Summary: Merck’s 15% decline in July is presenting investors with an intermediate to long-term buying
Summary: I think Walmart can trade to $100 per share easily with ‘flywheel’ innovation and
Summary: Merck faces significant challenges, including increased competition and regulatory scrutiny for Keytruda. Keytruda is
Summary: Merck’s reduced profit guidance is primarily due to recent acquisitions, but the company remains
Summary: Despite Merck beating analysts’ expectations for the second quarter of 2024, its stock price
Summary: The prime culprit for yesterday’s 9.8% drop in Merck was what seemed to be
Summary: Both Merck and Pfizer are expected to report their Q2 ’24 financial results on
Summary: Merck & Co will announce Q2 2024 earnings on July 30th. Merck’s share price
Summary: Merck’s price rise might have stalled in the past quarter, but at least for
Summary: Merck offers strong forward earnings growth trends and a compelling current valuation, making it